UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Iron deprivation blocks multilineage haematopoietic differentiation by inhibiting induction of p21(WAF1/CIP1)

British journal of haematology, 2007-05, Vol.137 (3), p.252-261

2007

Volltextzugriff (PDF)

Differentiation of functional dendritic cells and macrophages from human peripheral blood monocyte precursors is dependent on expression of p21 (WAF1/CIP1) and requires iron

British journal of haematology, 2002-06, Vol.117 (3), p.727-734

2002

Volltextzugriff (PDF)

Connective tissue growth factor (CTGF) expression and outcome in adult patients with acute lymphoblastic leukemia

Blood, 2007-04, Vol.109 (7), p.3080-3083

2007

Volltextzugriff (PDF)

Phase I trial of 90-minute infusion of the fusion toxin DAB486IL-2 in hematological cancers

Cancer research (Chicago, Ill.), 1993-09, Vol.53 (17), p.3930-3934

1993

Volltextzugriff (PDF)

New Perspectives on Iron: An Introduction

The American journal of the medical sciences, 1999-10, Vol.318 (4), p.207-212

Boldt, David H.

1999

Volltextzugriff (PDF)

New Perspectives on Iron: An Introduction

The American journal of the medical sciences, 1999-10, Vol.318 (4), p.207

BOLDT, DAVID H.

1999

Volltextzugriff (PDF)

Effects of tamoxifen on human breast cancer cell cycle kinetics: accumulation of cells in early G1 phase

Cancer research (Chicago, Ill.), 1983-08, Vol.43 (8), p.3583-3585

1983

Volltextzugriff (PDF)

Expression of different NF-κB pathway genes in dendritic cells (DCs) or macrophages assessed by gene expression profiling

Journal of cellular biochemistry, 2001, Vol.83 (2), p.281-290

2001

Volltextzugriff (PDF)

Iron Status Affects Specificity Protein (Sp) Binding but Not Histone Acetylation at the p21WAF1/CIP1 Gene Promoter during Differentiation of HL-60 Cells

Blood, 2005-11, Vol.106 (11), p.2723-2723

2005

Volltextzugriff (PDF)

p21CIP1/WAF1/SDI1 hypermethylation: an exciting new lead in ALL biology

Blood, 2002-04, Vol.99 (7), p.2283-2283

Boldt, David H.

2002

Volltextzugriff (PDF)

Human breast cancer cell cycle synchronization by estrogens and antiestrogens in culture

Cancer research (Chicago, Ill.), 1984-04, Vol.44 (4), p.1433-1439

1984

Volltextzugriff (PDF)

Expression of multiple genes regulating cell cycle and apoptosis in differentiating hematopoietic cells is dependent on iron

Experimental hematology, 2001-09, Vol.29 (9), p.1060-1069

2001

Volltextzugriff (PDF)

Phase II trials of high-dose interleukin-2 and lymphokine-activated killer cells in advanced breast carcinoma and carcinoma of the lung, ovary, and pancreas and other tumors

Journal of immunotherapy (1997), 1994-10, Vol.16 (3), p.216-223

1994

Volltextzugriff (PDF)

Excretion of DNA by purified human lymphocyte subpopulations

The Journal of immunology (1950), 1977-04, Vol.118 (4), p.1495-1498

1977

Volltextzugriff (PDF)

Randomized phase II trial of high-dose interleukin-2 either alone or in combination with interferon alfa-2b in advanced renal cell carcinoma

Journal of clinical oncology, 1993-04, Vol.11 (4), p.661-670

1993

Volltextzugriff (PDF)

Ig Heavy Chain Third Complementarity Determining Regions (H CDR3s) After Stem Cell Transplantation Do Not Resemble the Developing Human Fetal H CDR3s in Size Distribution and Ig Gene Utilization

Blood, 1998-10, Vol.92 (8), p.2802-2814

1998

Volltextzugriff (PDF)

Cell cycle regulatory gene abnormalities are important determinants of leukemogenesis and disease biology in adult acute lymphoblastic leukemia

Blood, 2000-04, Vol.95 (7), p.2364-2371

2000

Volltextzugriff (PDF)

A randomized phase II trial of continuous infusion interleukin-2 or bolus injection interleukin-2 plus lymphokine-activated killer cells for advanced renal cell carcinoma

Journal of clinical oncology, 1992-02, Vol.10 (2), p.275-281

1992

Volltextzugriff (PDF)

CTGF (CCN2) Predicts OS and DFS in Adult Acute Lymphoblastic Leukemia

Blood, 2005-11, Vol.106 (11), p.336-336

2005

Volltextzugriff (PDF)

Phase I evaluation and pharmacokinetics of tiazofurin (2-β-D-ribofuranosylthiazole-4-carboxamide, NSC 286193)

Cancer research (Chicago, Ill.), 1985-06, Vol.45 (6), p.2859-2865

1985

Volltextzugriff (PDF)

Guidelines for clinical protocols for chronic lymphocytic leukemia: Recommendations of the national cancer institute‐sponsored working group

American journal of hematology, 1988-11, Vol.29 (3), p.152-163

1988

Volltextzugriff (PDF)

Phase I clinical trial of carbetimer

Cancer research (Chicago, Ill.), 1988-09, Vol.48 (18), p.5353-5357

1988

Volltextzugriff (PDF)

Inhibition of Tartrate-Resistant Acid Phosphatase Gene Expression by Hemin and Protoporphyrin IX. Identification of a Hemin-Responsive Inhibitor of Transcription

Blood, 1996-09, Vol.88 (6), p.2288-2297

1996

Volltextzugriff (PDF)

A phase II study of high-dose continuous infusion interleukin-2 with lymphokine-activated killer cells in patients with metastatic melanoma

Journal of clinical oncology, 1991-04, Vol.9 (4), p.641-648

1991

Volltextzugriff (PDF)

A phase II study of high dose ARA-C and mitoxantrone for treatment of relapsed or refractory adult acute lymphoblastic leukemia

Leukemia research, 2000-03, Vol.24 (3), p.183-187

2000

Volltextzugriff (PDF)

1 – 25 von 103

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(94)
Mit Volltextzugriff
(82)

Publikationsform

Sprache

Englisch
(103)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Iron deprivation blocks multilineage haematopoietic differentiation by inhibiting induction of p21(WAF1/CIP1)

Differentiation of functional dendritic cells and macrophages from human peripheral blood monocyte precursors is dependent on expression of p21 (WAF1/CIP1) and requires iron

Connective tissue growth factor (CTGF) expression and outcome in adult patients with acute lymphoblastic leukemia

Phase I trial of 90-minute infusion of the fusion toxin DAB486IL-2 in hematological cancers

New Perspectives on Iron: An Introduction

New Perspectives on Iron: An Introduction

Effects of tamoxifen on human breast cancer cell cycle kinetics: accumulation of cells in early G1 phase

Expression of different NF-κB pathway genes in dendritic cells (DCs) or macrophages assessed by gene expression profiling

Iron Status Affects Specificity Protein (Sp) Binding but Not Histone Acetylation at the p21WAF1/CIP1 Gene Promoter during Differentiation of HL-60 Cells

p21CIP1/WAF1/SDI1 hypermethylation: an exciting new lead in ALL biology

Human breast cancer cell cycle synchronization by estrogens and antiestrogens in culture

Expression of multiple genes regulating cell cycle and apoptosis in differentiating hematopoietic cells is dependent on iron

Phase II trials of high-dose interleukin-2 and lymphokine-activated killer cells in advanced breast carcinoma and carcinoma of the lung, ovary, and pancreas and other tumors

Excretion of DNA by purified human lymphocyte subpopulations

Randomized phase II trial of high-dose interleukin-2 either alone or in combination with interferon alfa-2b in advanced renal cell carcinoma

Ig Heavy Chain Third Complementarity Determining Regions (H CDR3s) After Stem Cell Transplantation Do Not Resemble the Developing Human Fetal H CDR3s in Size Distribution and Ig Gene Utilization

Cell cycle regulatory gene abnormalities are important determinants of leukemogenesis and disease biology in adult acute lymphoblastic leukemia

A randomized phase II trial of continuous infusion interleukin-2 or bolus injection interleukin-2 plus lymphokine-activated killer cells for advanced renal cell carcinoma

CTGF (CCN2) Predicts OS and DFS in Adult Acute Lymphoblastic Leukemia

Phase I evaluation and pharmacokinetics of tiazofurin (2-β-D-ribofuranosylthiazole-4-carboxamide, NSC 286193)

Guidelines for clinical protocols for chronic lymphocytic leukemia: Recommendations of the national cancer institute‐sponsored working group

Phase I clinical trial of carbetimer

Inhibition of Tartrate-Resistant Acid Phosphatase Gene Expression by Hemin and Protoporphyrin IX. Identification of a Hemin-Responsive Inhibitor of Transcription

A phase II study of high-dose continuous infusion interleukin-2 with lymphokine-activated killer cells in patients with metastatic melanoma

A phase II study of high dose ARA-C and mitoxantrone for treatment of relapsed or refractory adult acute lymphoblastic leukemia

Suchergebnisse filtern